Clinical Trial Update: Coronary Sinus Reducer in Coronary Microvascular Disease [NA]

View source ↗

Summary

A clinical trial is enrolling by invitation to evaluate the Coronary Sinus Reducer for patients with stable angina and coronary microvascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Disease
• Stable Angina

Drugs mentioned

• Coronary Sinus Reducer

Snippet

Sponsor: UMC Utrecht | Conditions: Angina (Stable), Coronary Microvascular Disease | NA | Status: ENROLLING_BY_INVITATION